Nuformix (LON:NFX) Hits New 1-Year Low – What’s Next?

by · The Markets Daily

Nuformix plc (LON:NFX – Get Free Report)’s stock price hit a new 52-week low during trading on Monday . The stock traded as low as GBX 0.04 ($0.00) and last traded at GBX 0.05 ($0.00), with a volume of 157020219 shares changing hands. The stock had previously closed at GBX 0.06 ($0.00).

Nuformix Price Performance

The stock’s 50 day simple moving average is GBX 0.10 and its 200 day simple moving average is GBX 0.15. The firm has a market capitalization of £442,427.40, a P/E ratio of -1.63 and a beta of 1.22. The company has a debt-to-equity ratio of 1.17, a quick ratio of 3.35 and a current ratio of 1.12.

Nuformix Company Profile

(Get Free Report)

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.

Featured Stories